The largest database of trusted experimental protocols

Powerplex s5 system

Manufactured by Promega

The PowerPlex S5 system is a genetic analysis tool designed for human identification and forensic applications. It enables the simultaneous amplification and detection of five short tandem repeat (STR) loci in a single reaction. The system provides a reliable and efficient method for DNA profiling and personal identification.

Automatically generated - may contain errors

5 protocols using powerplex s5 system

1

Genetic Screening for Epileptic Spasms

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used molecular inversion probes to capture all exons and 5 base pairs of flanking intronic DEPDC5 sequence; next-generation sequencing and data analysis were performed as described previously in 130 patients with epileptic spasms of unknown etiology.15 (link),18 (link) Known epileptic encephalopathy genes had been excluded in many cases (unpublished data, Carvill et al., January 2015).18 (link)We considered only nonsynonymous, splice site, or frameshift variants that were present at an allele frequency <1% in ∼61,000 exomes of the Exome Aggregation Consortium (ExAC) data set (to exclude single nucleotide polymorphisms) (http://exac.broadinstitute.org/) for further analysis and performed segregation analysis for these rare variants in available family members. We considered truncating variants to be pathogenic and missense variants that were either inherited from an affected parent or arose de novo to be possibly pathogenic. Maternity/paternity was confirmed using the PowerPlex S5 system (Promega, Madison, WI). We included an additional novel DEPDC5 case, identified through commercial genetic testing (D:II:1), and additional phenotypic data on cousins from our earlier report (family E).1 (link)
+ Open protocol
+ Expand
2

Epilepsy Exome Sequencing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
We captured all USP9X exons and at least five base pairs of flanking sequence using molecular inversion probes, and performed next generation sequencing and data analysis as described previously.[39 (link)] Our resequencing cohort consisted of 284 males diagnosed with epileptic encephalopathy according to the International League Against Epilepsy (ILAE) classification criteria.[40 (link)] We considered only non-synonymous, frameshift or splice-site mutations that were rare (<2%) in the ESP6500 data set (see web resources) for further analysis. Segregation analysis using Sanger sequencing was performed where possible for variants that met these criteria, and paternity/maternity confirmed using the PowerPlex S5 system [Promega].
+ Open protocol
+ Expand
3

Confirming Parental Relationships

Check if the same lab product or an alternative is used in the 5 most similar protocols
Deletion breakpoints were refined in patient #2 using long-range PCR as described in the Supporting Information.
Microsatellite analysis (patient #5, PowerPlex S5 System, Promega) or CNV segregation studies (patient #2) were used to confirm maternity and paternity.
+ Open protocol
+ Expand
4

Mycoplasma Detection and STR Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell supernatants were tested for mycoplasma using the PCR Mycoplasma Test Kit I/C from PromoKine (cat. PK-CA91-1096). Genomic DNA was isolated using High Pure PCR Template Preparation Kit (Roche Life Science, cat. 11796828001), and five STR regions were amplified with fluorescently labeled primers (PowerPlex S5 System, Promega, cat. TMD021) (Table 1); the ABI PRISM 3100-Avant Genetic Analyzer and the GeneMapper ID software (v4.1) were used for detecting amplification products and analysis, respectively (Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen).
+ Open protocol
+ Expand
5

Genetic Variant Validation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Segregation analysis was carried out on all rare protein effecting variants by targeted sequencing. Variants were considered pathogenic or likely-pathogenic according to ACMG guidelines(Richards et al., 2015 ). In all families with an identified de novo mutation, we used microsatellite analysis (PowerPlex S5 system, Promega) or targeted capture (smMIPs) of an in house 51 single nucleotide polymorphism (SNP) marker set to confirm relatedness of the trio. All reported variants were validated by Sanger sequencing.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!